Neuroglee gets $2.3 million to develop digital therapeutics for neurodegenerative diseases

TechCrunch

Neuroglee , a Singapore-based health tech startup, wants to help with a digital therapeutic platform created to treat patients in the early stages of the disease. SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis.

[DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D

OurCrowd

The post [DarioHealth in PR Newswire] Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care D appeared first on OurCrowd Blog. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

[DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m.

[DarioHealth in PR Newswire] DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.

[DarioHealth in PR Newswire] DarioHealth Announces Hiring of Leading Digital Health Innovator as Senior Vice President of Employer Sales

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. NEW YORK, Jan. 21, 2021 /PRNewswire/ — DarioHealth Corp.

[DarioHealth in Yahoo Finance] Walmart Starts Distributing the DarioHealth Digital Diabetes Management System

OurCrowd

Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here.

[DarioHealth in Yahoo Finance] DarioHealth Announces Poster Presentation at the Virtual Association of Diabetes Care and Education Specialists 2020 Annual Conference

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.

[DarioHealth in PR Newswire] DarioHealth® Clinical Study Data Shows the Dario Membership Program Assists Diabetes Patients in Achieving Pre-Diabetic Blood-Glucose Levels and Consistent In-Range Measurements

OurCrowd

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

[Medisafe in PR Newswire] Medisafe Adds Pharmacy Integration to Its Platform, Now Delivers Medications to Patients

OurCrowd

[Medisafe in New Kerala] Medisafe and Everyday Health Team up to Provide Patients with Coronavirus Updates

OurCrowd

Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

[DarioHealth in Yahoo Finance] DarioHealth Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S.

[DarioHealth in Yahoo Finance] DarioHealth Expands Offering to Include Behavioral Health

OurCrowd

NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.

[Medisafe in Vator News] Today’s entrepreneur: Omri Shor

OurCrowd

Today’s entrepreneur is Omri Shor is co-founder and CEO of Medisafe, a digital therapeutic companion company helping patients manage their treatment journey and medication therapies, which just raised a $30 million round of funding.

[DarioHealth in FDA Health News] DARIOHEALTH: Self-test Blood Glucose Meters Can Now Be Utilized Within Hospitals During the COVID-19 Pandemic Per Recently Issued Emergency FDA Guidelines

OurCrowd

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.

[Medisafe in PR Newswire] Medisafe Earns Two Prestigious Digital Healthcare Awards

OurCrowd

3, 2021 /PRNewswire/ — Medisafe, a leading digital therapeutics company, named Best Medication Reminder App by OnlineDoctor.com while AVA Digital Awards named Medisafe a Platinum Award Winner in the ‘App for Medical’ category. BOSTON, Feb.

[DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons

OurCrowd

NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.

[Medisafe in McNight’s] Medisafe Maestro aims to bring precision to medication adherence

OurCrowd

Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.

[DarioHealth in PR Newswire] DarioHealth Announces Participation in Stephens Virtual Best Ideas Conference

OurCrowd

NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference on March 11, 2021. NEW YORK, March 5, 2021 /PRNewswire/ — DarioHealth Corp.

MedRhythms Uses the Universal Language of Music to Bring Hope, Healing to Mobility Impaired Patients

Angel Capital Association

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ).

[DarioHealth in Globes] DarioHealth raises $21.3m in private placement

OurCrowd

The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform.

[DarioHealth in Yahoo Finance] DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

OurCrowd

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp.

[DarioHealth in PR Newswire] DarioHealth® Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

OurCrowd

Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

[Medisafe in Yahoo Finance] Medisafe Stimulates Patient Connectivity to Combat COVID-19 Social Distancing Challenges

OurCrowd

BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19. Read more here.

[Medisafe in PR Newswire] UCB taps Medisafe in development of digital companion to support patient engagement

OurCrowd

Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug companions for its epilepsy medications.

[Medisafe in PR Newswire] Medisafe Brings Precision and Speed to Patient Journeys with new Medisafe Maestro technology

OurCrowd

Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform.

[DarioHealth in StreetInsider.com] DarioHealth Appoints Eric Milledge as Chairman of its Newly Established Scientific Advisory Board

OurCrowd

a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform.

[Medisafe in HIT Consultant] Medisafe Launches New Platform for Medication Management to Improve Patient Journey

OurCrowd

Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform.

[DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes

OurCrowd

DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. The post [DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes appeared first on OurCrowd.

[DarioHealth in BioSpace] DarioHealth Launches New Blood Pressure Monitoring System

OurCrowd

DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels.

[DarioHealth in PR Newswire] DarioHealth Launches New Blood Pressure Monitoring System

OurCrowd

Nasdaq: DRIO), (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. DarioHealth Corp.

[DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

[DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

[DarioHealth in Yahoo Finance] DarioHealth Announces Alliance with DigitalHealth.London As Part of the UK Israel Dangoor Health Initiative

OurCrowd

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) ”) as part of its UK Israel Dangoor Health Initiative (the “Initiative”), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.

FDA: Orientation for Early Stage Startups

Y Combinator

In addition, the FDA demands your plan for testing the product’s safety and efficacy in humans throughout the three Phases of therapeutic clinical trials 2. We describe the major ones here: Therapeutic Submissions. Emerging Therapeutic Areas. Digital Health.

[Medisafe in HIT Consultant] Consumers Cite Trump as Leading Driver of COVID-19 Vaccine Skepticism

OurCrowd

Real-world results show users prefer to wait on COVID-19 vaccine dose, refer to a physician for guidance on timing, according to a new survey from Medisafe, a digital therapeutics platform that supports users with advanced medication management.